Semaglutide (Ozempic, Wegovy) works entirely through this single receptor
Eligibility for liraglutide for weight loss is: Body Mass Index BMI 30 or higher or 27 or higher with weight related condition
8 Societal changes driven by uptake of GLP-1 weight loss medications The sweeping changes in food preference and appetite brought on by GLP-1RA pharmacotherapies are producing extensive downstream effects that reach beyond the individual, shaping broader cultural, social, and economic landscapes
* Metabolic health: Lower waist circumference, glucose, insulin, triglycerides, CRP
Cognitive versus behavioral skills in CBT for depressed adolescents: Disaggregating within-patient versus between-patient effects on symptom change
Use of GLP-1 agonists is becoming increasingly more common in the U.S